全文获取类型
收费全文 | 34040篇 |
免费 | 2101篇 |
国内免费 | 755篇 |
专业分类
耳鼻咽喉 | 388篇 |
儿科学 | 738篇 |
妇产科学 | 1247篇 |
基础医学 | 3412篇 |
口腔科学 | 1333篇 |
临床医学 | 3814篇 |
内科学 | 4383篇 |
皮肤病学 | 223篇 |
神经病学 | 2864篇 |
特种医学 | 974篇 |
外国民族医学 | 1篇 |
外科学 | 7482篇 |
综合类 | 4400篇 |
预防医学 | 1275篇 |
眼科学 | 350篇 |
药学 | 2565篇 |
21篇 | |
中国医学 | 789篇 |
肿瘤学 | 637篇 |
出版年
2024年 | 27篇 |
2023年 | 564篇 |
2022年 | 877篇 |
2021年 | 1532篇 |
2020年 | 1577篇 |
2019年 | 1396篇 |
2018年 | 1368篇 |
2017年 | 1083篇 |
2016年 | 1106篇 |
2015年 | 1147篇 |
2014年 | 2168篇 |
2013年 | 2350篇 |
2012年 | 1716篇 |
2011年 | 1990篇 |
2010年 | 1651篇 |
2009年 | 1580篇 |
2008年 | 1494篇 |
2007年 | 1415篇 |
2006年 | 1348篇 |
2005年 | 1177篇 |
2004年 | 1065篇 |
2003年 | 874篇 |
2002年 | 745篇 |
2001年 | 621篇 |
2000年 | 568篇 |
1999年 | 469篇 |
1998年 | 435篇 |
1997年 | 402篇 |
1996年 | 381篇 |
1995年 | 394篇 |
1994年 | 369篇 |
1993年 | 288篇 |
1992年 | 281篇 |
1991年 | 224篇 |
1990年 | 212篇 |
1989年 | 184篇 |
1988年 | 214篇 |
1987年 | 179篇 |
1986年 | 168篇 |
1985年 | 221篇 |
1984年 | 180篇 |
1983年 | 125篇 |
1982年 | 166篇 |
1981年 | 135篇 |
1980年 | 95篇 |
1979年 | 80篇 |
1978年 | 83篇 |
1977年 | 46篇 |
1976年 | 32篇 |
1975年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 312 毫秒
1.
《Obstetrics, Gynaecology and Reproductive Medicine》2020,30(6):175-183
Menopause is generally experienced as a biopsychosocial process involving physiological changes, and influenced by a wide range of psychological, social and cultural factors. The loss of ovarian oestrogen production may cause debilitating symptoms, including hot flushes, night sweats, sleep disturbance, vaginal dryness, dyspareunia, bladder dysfunction, loss of libido, and mood changes. Experience of the menopause transition varies widely between individuals, depending on the age of onset, personal health and wellbeing, social context, environment and culture.Hormone Replacement Therapy (HRT) remains the most effective treatment for the management of vasomotor symptoms and vaginal dryness, but has no proven role in the treatment of chronic diseases of ageing. Treatment should be individualized, and for most healthy women aged 50–59 years the risks of HRT are low. An understanding of the pathophysiology of menopausal symptoms and the risks and benefits of both hormonal and non-hormonal treatments assists in the individual management of patients. 相似文献
2.
3.
目的:探讨胃癌患者根治术后腹腔冲洗液中CEA mRNA表达情况及其临床意义。方法: 回顾性分析了2013 年1 月至2017 年12 月在南京大学医学院附属鼓楼医院接受胃癌根治切除术后进行腹腔灌洗液CEA mRNA检测的139 名患者的病历资料,并进行术后常规随访。用RT-PCR检测139 胃癌患者根治术后腹腔灌洗液中CEA mRNA表达情况。卡方检验分析腹腔灌洗液中CEA mRNA表达与临床基本特征、组织病理学资料、血液学指标及复发方式之间的关系。采用Logistic 单因素及多因素回归分析筛查影响CEA mRNA表达水平的因素。结果:139 名患者中44 名(31.7%)患者腹腔灌洗液CEA mRNA阳性。分析显示,胃癌患者腹腔灌洗液CEA mRNA阳性表达与性别、年龄、病理分级、Lauren 分型和HER2、EGFR、VEGFR等标记物间均没有明显的关联(均P>0.05),与病理类型、脉管是否侵犯、局部浸润深度、淋巴结转移程度和临床AJCC 分期有明显的关联(均P<0.05)。CEA mRNA阳性患者腹膜复发率明显高于阴性患者(P=0.012)。Logistic 单因素回归分析显示,印戒细胞癌(P=0.04,HR=2.810,95% CI: 1.050~7.520)、T 分期(P=0.016,HR=6.329,95% CI: 1.417~28.264)、N 分期(P=0.022,HR=3.068,95% CI: 1.172~8.027)、AJCC分期(P=0.016 ,HR=3.971 ,95% CI: 1.295~12.173 )、神经侵犯(P=0.002 ,HR=6.738,95% CI: 1.995~22.757)、脉管侵犯(P<0.001,HR=16.36,95% CI: 3.85~69.512)为胃癌患者腹腔灌洗液CEA mRNA阳性表达的危险因素。Logistic 多因素回归分析显示,经过对其他因素的校正,脉管侵犯(P<0.001,HR=21.314,95% CI: 4.21~107.907)为胃癌患者腹腔灌洗液CEA mRNA阳性表达的独立危险因素。结论:胃癌腹腔灌洗CEA mRNA阳性的患者腹膜复发转移风险高且预后不良,应考虑包括腹腔局部治疗在内的更加积极的抗肿瘤治疗。 相似文献
4.
5.
Elizabeth D. Krebs Robert B. Hawkins J. Hunter Mehaffey Clifford E. Fonner Alan M. Speir Mohammed A. Quader Jeffrey B. Rich Leora T. Yarboro Nicholas R. Teman Gorav Ailawadi 《The Journal of thoracic and cardiovascular surgery》2019,157(4):1533-1542.e2
Objectives
Expedient extubation after cardiac surgery has been associated with improved outcomes, leading to postoperative extubation frequently during overnight hours. However, recent evidence in a mixed medical-surgical intensive care unit population demonstrated worse outcomes with overnight extubation. This study investigated the impact of overnight extubation in a statewide, multicenter Society of Thoracic Surgeons database.Methods
Records from 39,812 patients undergoing coronary artery bypass grafting or valve operations (2008-2016) and extubated within 24 hours were stratified according to extubation time between 06:00 and 18:00 (day) or between 18:00 and 6:00 (overnight). Outcomes including reintubation, mortality, and composite morbidity-mortality were evaluated using hierarchical regression models adjusted for Society of Thoracic Surgeons predictive risk scores. To further analyze extubation during the night, a subanalysis stratified patients into 3 groups: 06:00 to 18:00, 18:00 to 24:00, and 24:00 to 06:00.Results
A total of 20,758 patients were extubated overnight (52.1%) and were slightly older (median age 66 vs 65 years, P < .001) with a longer duration of ventilation (4 vs 7 hours, P < .001). Day and overnight extubation were associated with equivalent operative mortality (1.7% vs 1.7%, P = .880), reintubation (3.7% vs 3.4%, P = .141), and composite morbidity-mortality (8.2% vs 8.0%, P = .314). After risk adjustment, overnight extubation was not associated with any difference in reintubation, mortality, or composite morbidity-mortality. On subanalysis, those extubated between 24:00 and 06:00 exhibited increased composite morbidity-mortality (odds ratio, 1.18; P = .001) but no difference in reintubation or mortality.Conclusions
Extubation overnight was not associated with increased mortality or reintubation. These results suggest that in the appropriate clinical setting, it is safe to routinely extubate cardiac surgery patients overnight. 相似文献6.
7.
8.
9.
10.